Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EASE in Psoriasis
NCT00116181Phase 3Completed
- Sponsor
- The Rockefeller University
- Start
- Oct 2004
- Primary completion
- Jan 2007
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of etanercept in plaque psoriasis (2 arms), sponsored by The Rockefeller University. Primary endpoint: Proportion of subjects achieving a responder status on the Physician's Global Assessment (PGA) at 24 weeks. Started Oct 2004; status: completed.
02
Drugs
etanercept
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00116181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00116181.